Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed.

1. T-cadherin as a potential novel regulator of intestinal inflammation and fibrosis.Frontiers in physiology · 2026
   Review
2. Genetically Validated Immune Susceptibility Markers for Crohn's Disease: A Multi-Omics Mendelian Randomization Analysis.JGH open : an open access journal of gastroenterology and hepatology · 2026
   Article
3. Inflammatory Bowel Disease and Mental Health: The Complex Relationship Between Gut and Brain.Cureus · 2025
   Article
4. Prevalence of Anxiety and Depressive Disorders Among Patients Diagnosed With Inflammatory Bowel Disease.Journal of clinical medicine research · 2025
   Article
5. Colo-Protective Effects of Pentoxifylline Alone or in Combination With Mesalamine in Colitis Through Sphingosine Kinase 1/Sphingosine 1 Phosphate, and Zonula Occuldin 1 Pathways: New Molecular Approach.Pharmacology research & perspectives · 2025
   Article
6. Gut Microbiota: An Immersion in Dysbiosis, Associated Pathologies, and Probiotics.Microorganisms · 2025
   Review
7. "Clinical epidemiology of inflammatory bowel disease among adults in the South Asian region: A systematic review and meta-analysis".Heliyon · 2025
   Article
8. Potential Phytotherapy of DSS-Induced Colitis: Ameliorating Reactive Oxygen Species-Mediated Necroptosis and Gut Dysbiosis with a NewAntioxidants (Basel, Switzerland) · 2024
   Article
9. The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease.Cureus · 2023
   Review
10. Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease.World journal of clinical cases · 2023
    Review
11. Bone Mineral Density in Patients with Pediatric Inflammatory Bowel Disease Using Dual Energy X-Ray Absorptiometry.Journal of bone metabolism · 2023
    Article
12. Mitochondrial Control in Inflammatory Gastrointestinal Diseases.International journal of molecular sciences · 2022
    Review
13. Proton pump inhibitors use and risk of inflammatory bowel diseases: a meta-analysis of observational studies.Medicine and pharmacy reports · 2022
    Review
14. The Combination of Intestinal Alkaline Phosphatase Treatment with Moderate Physical Activity Alleviates the Severity of Experimental Colitis in Obese Mice via Modulation of Gut Microbiota, Attenuation of Proinflammatory Cytokines, Oxidative Stress Biomarkers and DNA Oxidative Damage in Colonic Mucosa.International journal of molecular sciences · 2022
    Article
15. Host-Viral Interactions in the Pathogenesis of Ulcerative Colitis.International journal of molecular sciences · 2021
    Review
16. Oxyresveratrol Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats by Suppressing Inflammation.Molecules (Basel, Switzerland) · 2021
    Article
17. Therapeutic Application of Exosomes in Inflammatory Diseases.International journal of molecular sciences · 2021
    Review
18. Dynamics of the Stool Virome in Very Early-Onset Inflammatory Bowel Disease.Journal of Crohn's & colitis · 2020
    Article
19. Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer.Cancer immunology research · 2020
    Article
20. Effects ofPharmaceuticals (Basel, Switzerland) · 2018
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.